Forecast & Rating13 analysts currently cover Prime Medicine, with about 69.2% giving a positive rating — meaning they expect the stock to rise. The average price target is $7.13, about 130.6% upside from the current price of $3.09. Price targets range from $4.25 to $11.00 — a wide spread, showing clear disagreement over just how much Prime Medicine can rise. For you, this means most professionals who study Prime Medicine closely still see room for the stock to rise. Data as of Aug 12, 2026; for reference only and not investment advice.
Aug 10, 2026Price forecast
$7.13130.58%
Forecast & RatingBuy
12analysts
- Strong buy66.67%
- Buy8.33%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 9, 2026
Forecast met4.6%
Stock price$3.09
Avg. target$6.4
High target$9
Low target$4
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.